ClinicalTrials.gg
Active, not recruitingNCT07950033Updated Nov 20, 2026

A Study to Evaluate the Effects of the EMF Harmony Products on Health Parameters Associated With EMF Radiation Exposure

An interventional study of Placebo Intervention and EMF Harmony Intervention in Electromagnetic Hypersensitivity, Idiopathic Environmental Intolerance Attributed to Electromagnetic Fields and Sleep Disturbance, sponsored by Life Harmony Energies, Inc.. Active, not recruiting at 1 site in United States. Open to participants aged 16 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Life Harmony Energies, Inc. · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Apr 2026, registered Nov 2026).
Updated Nov 20, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
16 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 58 studies in Mental Fatigue with a site in United States — 20 open to participants now, 25 under way, 1 of them phase 3. Mental Fatigue · United States.

Enrollment
11th of 49
60 · median 35
Started
2026
with 12 others
No phase
38 of 58
12 open now
Primary completion
2026-12
later than 6 of 24 live
Registered
58th of 58
by date

Among the 58 studies in Mental Fatigue with a site in United States, this one is the 11th largest by enrollment of the 49 interventional ones that give a count, is one of 13 that started in 2026, is one of 38 with no phase, reaches primary completion later than 6 of the 24 other live ones, and was the 58th registered.

Mental Fatigue

177 studies on the registry are indexed under Mental Fatigue; 55 are open to participants now.

Browse Mental Fatigue studies →

Open to participants now

20 of the 58 studies in Mental Fatigue with a site in United States are open now. Recruiting first, the newest first:

15 more — sign in →

All 20 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 30 Mental Fatigue studies recruiting now, 9 (30%) set no upper age limit and 20 (67%) stop at 75 or younger; 1 takes children under 18; 16 take healthy volunteers.

This study: 16 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 58 studies in Mental Fatigue with a site in United States, or all of them as a file.
02

Study summary

This is a randomized, double-blind, placebo-controlled, fully decentralized (virtual) clinical trial evaluating the effects of the EMF Harmony products (Pure Light Cuff and Smartwatch Chip) on health parameters associated with EMF radiation exposure. Sixty adult participants aged 18-65 will be randomized 1:1 to either the active treatment or an identical placebo for 6 weeks of continuous daily wear.

Participants will complete validated questionnaires at Baseline, Week 2, Week 4, and Week 6, and will wear a Fitbit Tracker throughout the study to collect objective data on sleep metrics, heart rate variability (HRV), and resting heart rate. The primary objective is to evaluate whether daily use of the EMF Harmony products produces measurable improvements in composite health parameters compared to placebo over 6 weeks.

03

Conditions studied

  • Electromagnetic Hypersensitivity
  • Idiopathic Environmental Intolerance Attributed to Electromagnetic Fields
  • Sleep Disturbance
  • Brain Fog
  • Headache
  • Tinnitus
  • Anxiety
04

Who can participate

Ages eligible
16 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy adults aged 18-65 years.
  • Owns and regularly uses a smartphone (daily use).
  • Has a wireless WiFi network in their home.
  • Resides in an urban or suburban environment in the United States.
  • Self-reports experiencing at least two of the following symptoms at least once per week over the past four weeks: sleep disturbances (difficulty falling asleep, staying asleep, or non-restorative sleep), mental fog or difficulty concentrating (brain fog), headaches, tingling or discomfort when holding or using a mobile phone.
  • Willing to wear the study cuff daily (24 hours/day, removing only for bathing and swimming) for the full 6-week study duration.
  • Willing to wear a Fitbit Tracker on the opposite wrist for the full 6-week study duration.
  • Willing to comply with all study procedures, including completion of questionnaires at all scheduled timepoints.
  • Has access to a compatible smartphone or computer for Fitbit data synchronization and completion of study questionnaires via the study platform.
  • Willing to maintain their current lifestyle habits (diet, exercise routine, sleep schedule, and electronic device usage patterns) for the duration of the trial.
  • Generally healthy - does not live with any uncontrolled chronic disease.

Exclusion criteria

Exclusion Criteria:

  • Known allergy or sensitivity to stainless steel, nickel, or other metals commonly found in jewelry.
  • Unwilling to discontinue using other smartwatches or sleep tracking devices for the duration of the study.
  • Active dermatological condition on the wrist(s) that would preclude comfortable wearing of a bracelet (e.g., severe eczema, open wounds, contact dermatitis at the wrist).
  • Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
  • Currently partaking in another research study or planning to partake in any other research study during the 6-week study duration.
  • Anyone who has initiated a new medication, supplement, or therapeutic regimen targeting sleep, cognitive function, or anxiety within the past 4 weeks, or who plans to do so during the study period.
  • Participants on stable medications (>=4 weeks) for these conditions are eligible.
  • Current use of another EMF-shielding or EMF-harmonizing device or product (e.g., EMF-blocking phone cases, pendants, or other wearable devices marketed for EMF protection).
  • Participants must be willing to discontinue use of such products for the study duration.
  • Diagnosed sleep disorder (e.g., obstructive sleep apnea, narcolepsy, restless leg syndrome).
  • Any condition that, in the judgment of the investigator, would make participation in the study unsafe or would significantly impair the participant's ability to comply with the study protocol.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    EMF Harmony Arm

    Dietary Supplement: Placebo Intervention

  • Active comparator
    Placebo Comparator

    Dietary Supplement: EMF Harmony Intervention

Interventions

  • Dietary supplementPlacebo Intervention

    All participants will wear their assigned cuff continuously (24 hours daily), removing it only for bathing and swimming, for the full 6-week study period.

  • Dietary supplementEMF Harmony Intervention

    All participants will wear their assigned cuff continuously (24 hours daily), removing it only for bathing and swimming, for the full 6-week study period.

06

What researchers measure

Primary outcomes

  1. Change from Baseline in Composite Health Score

    Change from Baseline to Week 6 in a composite health score derived from Fitbit-tracked metrics (total sleep time, sleep efficiency, HRV, resting heart rate) and self-reported overall health and well-being score, assessed by Fitbit Tracker (objective) and self-reported overall health and well-being questionnaire (subjective), compared between treatment and placebo groups

    Time frame: Baseline to Week 6

Secondary outcomes

  1. Change from Baseline in Self-Reported Sleep Quality

    Change from Baseline to Week 6 in global score assessed via the Pittsburgh Sleep Quality Index (PSQI)

    Time frame: Baseline to Week 6

  2. Change from Baseline in Self-Reported Mental Clarity and Brain Fog

    Change from Baseline to Week 6 in score assessed via the Mental Clutter Scale (self-reported questionnaire assessing brain fog, cognitive clarity, and mental focus)

    Time frame: Baseline to Week 6

  3. Change from Baseline in Self-Reported EMF-Related Discomfort Symptoms

    Change from Baseline to Week 6 in total score assessed via a symptom severity Visual Analog Scale (VAS; 100 mm scale per symptom domain) comprising tingling/discomfort during cell phone use, headaches, tinnitus, and anxiety sub-scales

    Time frame: Baseline to Week 6

  4. Change from Baseline in Fitbit-Derived Total Sleep Time

    Change from Baseline to Week 6 in total sleep time derived from Fitbit Tracker, compared between groups

    Time frame: Baseline to Week 6 (continuous daily data aggregated by week)

  5. Change from Baseline in Fitbit-Derived Sleep Efficiency

    Change from Baseline to Week 6 in sleep efficiency derived from Fitbit Tracker, compared between groups

    Time frame: Baseline to Week 6 (continuous daily data aggregated by week)

  6. Change from Baseline in Fitbit-Derived Sleep Stages

    Change from Baseline to Week 6 in proportion of sleep stages (deep, light, REM) derived from Fitbit Tracker, compared between groups

    Time frame: Baseline to Week 6 (continuous daily data aggregated by week)

  7. Change from Baseline in Fitbit-Derived Sleep Onset Latency

    Change from Baseline to Week 6 in sleep onset latency derived from Fitbit Tracker, compared between groups

    Time frame: Baseline to Week 6 (continuous daily data aggregated by week)

  8. Change from Baseline in Fitbit-Derived Heart Rate Variability

    Change from Baseline to Week 6 in HRV derived from Fitbit Tracker, compared between groups

    Time frame: Baseline to Week 6 (continuous daily data aggregated by week)

  9. Change from Baseline in Fitbit-Derived Resting Heart Rate

    Change from Baseline to Week 6 in resting heart rate derived from Fitbit Tracker, compared between groups

    Time frame: Baseline to Week 6 (continuous daily data aggregated by week)

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Dec 2026, 8 months after the start.

Of 94 interventional studies with no phase under Mental Fatigue, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 23. This study's planned 8 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2026
First posted
Nov 20, 2026
StartActual
Apr 7, 2026
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07950033
Lead sponsor
Life Harmony Energies, Inc.
Collaborators
Citruslabs
Responsible party
Sponsor
First posted
Nov 20, 2026
Start date
Apr 7, 2026
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Nov 20, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion